John P. Alderete, PhD, has successfully applied his decades of experience and formal training to the evaluation, financing, formation and operation of biotechnology and medical device technology companies. Currently he is the Founder and President of Folium BioMed™ LLC, an investment and product development and evaluation company, and CEO of Aspis Health™, Inc., a medical device development company based in Seattle, Washington.

John is the co-founder and former Vice President and Chief Scientific Officer of Xenotope Diagnostics Inc., a medical diagnostics company that develops novel, high-margin medical products for significant worldwide markets. Prior to forming Xenotope Diagnostics Inc., John was a senior consultant and project manager at Plan A, a pharmaceutical and biotechnology consulting firm in Palo Alto, California. His clients included leading multinational pharmaceutical and biotechnology companies such as Amgen, Inc., Aventis Pharmaceuticals, Inc., Biogen, Inc., Genentech, Inc., Imclone Systems, Inc., Ortho Biotech, and Virologic, Inc (now Monogram Biosciences).

John was previously the Senior Associate Director for Corporate and Foundation Relations at the Stanford University School of Medicine and recently served as the Chairman and CEO of Flora Bioscience, Inc., a Silicon-Valley medical diagnostics and device company focused on women’s health. 

John received his BA in Biology from Reed College, his PhD from the University of Washington in conjunction with the Fred Hutchinson Cancer Research Center and his MBA with distinction from the University of Texas.